SLOAN SHELDON (Chief Medical Officer) sold 78.33K shares of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.60M. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+78.33K
Price / share
$27.46
Trade value
$2.15M
% of position
Common Stock
Shares
−21.31K
Price / share
$69.53
Trade value
$1.48M
% of position
Common Stock
Shares
−19.66K
Price / share
$70.61
Trade value
$1.39M
% of position
Common Stock
Shares
−8.78K
Price / share
$71.56
Trade value
$628.08K
% of position
Common Stock
Shares
−12.78K
Price / share
$72.94
Trade value
$931.95K
% of position
Common Stock
Shares
−10.36K
Price / share
$73.74
Trade value
$763.80K
% of position
Common Stock
Shares
−5.06K
Price / share
$74.60
Trade value
$377.40K
% of position
Common Stock
Shares
−400.00
Price / share
$75.37
Trade value
$30.15K
% of position
Net shares
+0.00
Net value
-$3.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | M · Option Exercise | +78.33K | $27.46 | $2.15M | New position | 0.00 | 78.33K |
| Common Stock Direct | 5/1/2026 | S · Sale | −21.31K | $69.53 | $1.48M | 27.2% | 78.33K | 57.03K |
| Common Stock Direct | 5/1/2026 | S · Sale | −19.66K | $70.61 | $1.39M | 34.5% | 57.03K | 37.37K |
| Common Stock Direct | 5/1/2026 | S · Sale | −8.78K | $71.56 | $628.08K | 23.5% | 37.37K | 28.59K |
| Common Stock Direct | 5/1/2026 | S · Sale | −12.78K | $72.94 | $931.95K | 44.7% | 28.59K | 15.82K |
| Common Stock Direct | 5/1/2026 | S · Sale | −10.36K | $73.74 | $763.80K | 65.5% | 15.82K | 5.46K |
| Common Stock Direct | 5/1/2026 | S · Sale | −5.06K | $74.60 | $377.40K | 92.7% | 5.46K | 400.00 |
| Common Stock Direct | 5/1/2026 | S · Sale | −400.00 | $75.37 | $30.15K | New position | 400.00 | 0.00 |
| Total | +0.00 | -$3.45M | ||||||
Stock Option (Right to Buy)
Common Stock
78.33K shares
Shares
−78.33K
Strike price
27.46
Held after
321.67K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock78.33K shares | 5/1/2026 | M · Option Exercise | −78.33K | 27.46 | — | 321.67K |